The Droplet Digital PCR: A New Valid Molecular Approach for the Assessment of B-RAF V600E Mutation in Hairy Cell Leukemia-Reference-Cited by-同舟云学术

The Droplet Digital PCR: A New Valid Molecular Approach for the Assessment of B-RAF V600E Mutation in Hairy Cell Leukemia

Published:2016-10-13 Issue: Volume:7 Page:
ISSN:1663-9812
Container-title:Frontiers in Pharmacology
language:
Short-container-title:Front. Pharmacol.

Author:

Guerrini Francesca,Paolicchi Matteo,Ghio Francesco,Ciabatti Elena,Grassi Susanna,Salehzadeh Serena,Ercolano Giacomo,Metelli Maria R.,Del Re Marzia,Iovino Lorenzo,Petrini Iacopo,Carulli Giovanni,Cecconi Nadia,Rousseau Martina,Cervetti Giulia,Galimberti Sara

Publisher

Frontiers Media SA

Subject

Pharmacology (medical),Pharmacology

Reference49 articles.

1. BRAF mutation in hairy cell leukemia.;Ahmadzadeh;Oncol. Rev.,2014

2. The BRAF V600E mutation in hairy cell leukemia and other mature B-cell neoplasms.;Arcaini;Blood,2012

3. Minimal residual disease in hairy cell leukemia patients assessed by clone-specific polymerase chain reaction.;Arons;Clin. Cancer Res.,2006

4. European LeukemiaNet recommendations for the management of chronic myeloid leukemia: 2013.;Baccarani;Blood,2013

5. Droplet digital polymerase chain reaction for DNMT3A and IDH1/2 mutations to improve early detection of acute myeloid leukemia relapse after allogeneic hematopoietic stem cell transplantation.;Brambati;Haematologica,2016

Cited by 27 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Minimal residual disease detection in lymphoma: methods, procedures and clinical significance;Frontiers in Immunology;2024-08-12

2. Recommendations for the Management of Patients with Hairy-Cell Leukemia and Hairy-Cell Leukemia-like Disorders: A Work by French-Speaking Experts and French Innovative Leukemia Organization (FILO) Group;Cancers;2024-06-10

3. Identification of Multiclass Pediatric Low-Grade Neuroepithelial Tumor Molecular Subtype with ADC MR Imaging and Machine Learning;American Journal of Neuroradiology;2024-04-11

4. Detecting liquid remnants of solid tumors treated with curative intent: Circulating tumor DNA as a biomarker of minimal residual disease (Review);Oncology Reports;2023-04-12

5. Research Topic: Measurable Residual Disease in Hematologic Malignancies. Can digital droplet PCR improve measurable residual disease monitoring in chronic lymphoid malignancies?;Frontiers in Oncology;2023-03-14